“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z
4basebio signs strategic collaboration, marketing agreement with Genezen on synthetic DNA for viral vectors
Valerio Therapeutics signs deal to buy Etherna Immunotherapies for €30 million enterprise value
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2026 Q2 Revenue: USD 13.42 M
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 14.43 M
OMNIAB INC C/WTS (TO PUR COM) | 10-K: FY2025 Revenue: USD 18.67 M